Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zoli

Showing results (251-260 of 261) with videos related to

Pageof 27
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 5, 2015
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in miceL Ponzoni, M Moretti, M Sala, et al.
The European Journal of Neuroscience|April 26, 2003
Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptorsL M Marubio, A M Gardier, S Durier, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1996
Nicotinic receptors and brain plasticityJ P Changeux, A Bessis, J P Bourgeois, et al.
Gut|May 19, 2001
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosisA Gramenzi, P Andreone, S Fiorino, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2009
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinomaE G Giannini, G Bodini, M Corbo, et al.
Clinical Neuroradiology|September 29, 2021
MR Brain Screening in ADPKD Patients : To Screen or not to Screen?I Capelli, M Zoli, M Righini, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2000
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexesS Ginés, J Hillion, M Torvinen, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2016
Years of life that could be saved from prevention of hepatocellular carcinomaA Cucchetti, F Trevisani, L Bucci, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2015
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcomeL Bucci, F Garuti, V Camelli, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonS Petta, G Cabibbo, M Barbara, et al.
Pageof 27

Showing results (251-260 of 261) with videos related to

Sort By:
Pageof 27
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 5, 2015
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in miceL Ponzoni, M Moretti, M Sala, et al.
The European Journal of Neuroscience|April 26, 2003
Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptorsL M Marubio, A M Gardier, S Durier, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1996
Nicotinic receptors and brain plasticityJ P Changeux, A Bessis, J P Bourgeois, et al.
Gut|May 19, 2001
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosisA Gramenzi, P Andreone, S Fiorino, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2009
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinomaE G Giannini, G Bodini, M Corbo, et al.
Clinical Neuroradiology|September 29, 2021
MR Brain Screening in ADPKD Patients : To Screen or not to Screen?I Capelli, M Zoli, M Righini, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2000
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexesS Ginés, J Hillion, M Torvinen, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2016
Years of life that could be saved from prevention of hepatocellular carcinomaA Cucchetti, F Trevisani, L Bucci, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2015
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcomeL Bucci, F Garuti, V Camelli, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonS Petta, G Cabibbo, M Barbara, et al.
Pageof 27